Fixing American healthcare means fighting Big Pharma at home and abroad
Washington has finally decided to treat pharmaceutical supply chains as a national security risk, introducing new policies to wean America off foreign drug dependence. This strategy has been focused primarily, though not exclusively, on China.  The Trump administration recently announced actions that will cut red tape for new drug manufacturing facilities by reforming permitting, reducing […]
Original Source
Read the full article at Washingtonexaminer →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.